 | Up a level |
Park, Julie R., Villablanca, Judith G., Hero, Barbara, Kushner, Brian H., Wheatley, Keith, Beiske, Klaus H., Ladenstein, Ruth L., Baruchel, Sylvain, Macy, Margaret E., Moreno, Lucas, Seibel, Nita L., Pearson, Andrew D., Matthay, Katherine K. and Valteau-Couanet, Dominique (2022). Early-phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting. Cancer, 128 (21). S. 3775 - 3784. HOBOKEN: WILEY. ISSN 1097-0142
Scott, Kathleen, Hayden, Patrick J., Will, Andrea, Wheatley, Keith and Coyne, Imelda 
ORCID: 0000-0003-0977-8428
(2016).
Bortezomib for the treatment of multiple myeloma.
Cochrane Database Syst Rev. (4).
HOBOKEN:
WILEY.
ISSN 1361-6137